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257 RELIABILITY, VALIDITY AND FEASIBILITY OF THE DOYLE
INDEX, A PAIN MEASURE IN OSTEOARTHRITIS
J. Bijsterbosch, S. le Cessie, M. Wassenaar, D.M. van der Heijde,
F.R. Rosendaal, T.W. Huizinga, M. Kloppenburg. Leiden University
Medical Center, Leiden, NETHERLANDS
Purpose: Pain, a core outcome in osteoarthritis (OA) research, can be
measured during physical examination by an articular index called the
Doyle Index. The value of this pain score as an outcome measure in OA
is not established. In the present study the reliability, validity and feasibility
of this index will be determined.
Methods: The Doyle Index includes 48 joints or joint groups, being hands,
wrists, elbows, shoulders, acromioclavicular, sternoclavicular, hips, knees,
ankles, feet and spine. Pain is assessed by pressure on the joint margin
or by passive movement of the joint, scored on a four-point scale (0 = no
pain, 1 = pain, 2 = pain and wincing, 3 = pain, wincing and withdrawal of
the joint; range 0–144). The Doyle Index was performed by one observer
in 90 patients with OA at multiple joint sites in the hands or with OA in
two or more of the following joint sites: hand, knee, hip, cervical or lumbar
spine. Reliability and feasibility were determined in a random sample of
18 patients, by examining these patients twice with a 90 minutes time
interval, using four observers. Intraclass correlation coefﬁcients (ICC)
and their 95% conﬁdence intervals (95%CI) were calculated, as well
as the mean time it took each observer to perform the Doyle Index.
Validity was assessed by correlating Doyle Index scores obtained in the
whole population to the pain subscale scores of the Australian/Canadian
Osteoarthritis Hand Index (AUSCAN) and the Western Ontario and Mc-
Master Universities Osteoarthritis Index (WOMAC), using Spearman rank
coefﬁcient.
Results: The patient population consisted of 90 patients (82% women,
mean age 65.0 years). The median Doyle Index score for the whole
population was 9.5 (interquartile range (IQR) 4−16). The median score of
all observations in the sample of 18 patients was 16.5 (IQR 8.25−29.75).
Interobserver reliability was 0.88 (95% CI 0.77−0.94). Intraobserver reli-
abilities for the four observers ranged from 0.94 (95% CI 0.84−0.98) to
0.97 (95% CI 0.93−0.99). The mean time to perform the Doyle Index for
a single patient was between 4.0 and 6.0 minutes.
The Doyle Index scores correlated to the AUSCAN pain subscale (r = 0.48
(p< 0.001)) and to the WOMAC pain subscale (r = 0.45 (p< 0.001)).
Conclusions: The Doyle Index showed to be a reliable, valid and feasible
measure for the assessment of OA pain during physical examination.
Based on the ﬁndings of the present study, the Doyle Index is a promis-
ing outcome measure for pain in OA, although further research on its
clinimetric properties is advisable.
258 PAIN AND FUNCTIONAL DISABILITY IN SYMPTOMATIC
HAND OSTEOARTHRITIS DEPEND ON TYPE OF JOINT
INVOLVEMENT
J. Bijsterbosch, A.W. Visser, H.M. Kroon, T.W. Huizinga,
M. Kloppenburg. Leiden University Medical Center, Leiden,
NETHERLANDS
Purpose: Hand osteoarthritis (OA) can affect the carpometacarpal joints
(CMCJs) and the interphalangeal joints (IPJs). This study investigates
whether OA in the CMCJs or IPJs comprise different clinical entities.
Methods: Patients with familial OA who participate in the GARP (Genet-
ics ARthrosis and Progression) study, were eligible for the present study
if they had hand OA deﬁned by the American College of Rheumatology
criteria for clinical hand OA or the presence of structural abnormalities
(multiple bony swellings or radiological OA) in the hands. Patients were
assigned to 3 groups, based on self reported pain and/or stiffness in
CMCJs and IPJs. Group 1, 2 and 3 consisted of patients with symptoms
at the IPJs only, symptoms at the CMCJs only or symptoms at both sites,
respectively.
Hand pain and function were assessed with the Australian/Canadian
Osteoarthritis Hand Index (AUSCAN LK 3.0). CMCJs and IPJs were
evaluated for radiological damage on standardised radiographs using the
Kellgren-Lawrence (KL) grading scale.
Groups were compared using one-way ANOVA and the Kruskall-Wallis
test. Linear regression was used to adjust for number of symptomatic
joints, age, sex, body mass index (BMI) and family effects.
Results: Of the 308 hand OA patients (86% women, mean age
60.1 years, 87% fulﬁlling ACR criteria) participating in the present study,
138 (44.8%) were assigned to group 1, 20 (6.5%) to group 2 and
150 (48.7%) to group 3. Group 3 consisted of signiﬁcantly more women
(93%) compared to group 1 (81%) and 2 (75%). Other demographic
characteristics did not differ between the groups.
The median (interquartile range (IQR)) number of painful joints was 4.0
(2.0−8.0) for group 1, 2.0 (1.3−2.0) for group 2 and 7.0 (4.0−12.0) for
group 3. KL scores did not differ between the groups.
Median (IQR) AUSCAN total scores were 16.0 (9.3−26.0) for group 1,
23.0 (15.0−30.0) for group 2, and 28.0 (16.0−37.0) for group 3. After
adjustment for number of symptomatic joints, age, sex, BMI and family
effects, AUSCAN total scores were 5.7 points (95% CI 2.8−8.6) lower
for group 1 compared to group 3 and 7.7 points (95% CI 2.2−13.3)
lower compared to group 2. AUSCAN pain and function scores showed
the same pattern. AUSCAN scores were associated with the number of
symptomatic joints after adjustment for age, sex, BMI and family effects
(b=0.9 (95% CI 0.6−1.1) for AUSCAN total score).
Further regression analysis showed that AUSCAN total scores were
6.0 points (95% CI 3.8−8.7) higher for patients with symptomatic CMCJs
compared to patients without symptomatic CMCJs; AUSCAN pain scores
were 2.1 points (95% CI 1.2−3.1) higher and AUSCAN function scores
were 3.7 (95% CI 1.9−5.6) higher.
Conclusions: Pain and functional disability in hand OA seem to depend
not only on the number of symptomatic joints but also on the type of
joint involved. CMCJ OA is suggested to add more to self reported pain
and functional impairment than IPJ OA. Hence, treatment should focus
on CMCJ OA.
259 CHOOSING SURGERY: PATIENTS’ PREFERENCES WITHIN
A TRIAL OF TREATMENTS FOR ANTERIOR CRUCIATE
LIGAMENT INJURY
C.A. Thorstensson1, L.S. Lohmander2, R.B. Frobell2, E.M. Roos3,
R. Gooberman-Hill4. 1Research and Development Centre, Spenshult,
Oskarstro¨m, SWEDEN, 2Department of Orthopedics, Clinical Sciences,
Lund University, Lund, SWEDEN, 3Institute of Sports Science and
Clinical Biomechanics Faculty of Health Sciences University of Southern
Denmark, Odense, DENMARK, 4Department of Social Sciences, Bristol
University, Bristol, UNITED KINGDOM
Purpose: To understand patients’ views of treatment after acute anterior
cruciate ligament (ACL) injury, and their reasons for deciding to request
surgery.
Methods: 34 in-depth qualitative interviews with young (aged 18−35),
physically active individuals with ACL rupture who were participating in
a RCT comparing training and surgical reconstruction with training only.
22/34 were randomised to training only but crossed over to surgery. Of
these, 11 were interviewed before surgery, and 11 were interviewed
at least 6 months after surgery. 12 patients were interviewed before
randomisation. Interviews were audio-recorded, transcribed and analysed
using the Framework approach.
Results: Strong preference for surgery was commonplace and many
patients said that they joined the RCT in order to bypass waiting lists.
Patients who chose to cross-over to the surgery arm of the trial described
training as time consuming, boring and as unable to provide sufﬁcient
results within a reasonable timeframe. Some said their injured knees had
given-way during activity; others experienced new knee traumas; and
many described their lack of trust in their knee. Patients believed that
surgery would provide joint stability. Despite their ostensible satisfaction
with surgery, more detailed exploration showed that patients held mixed
views.
Conclusions: Participants in a trial of treatments for acute ACL injury
express a variety of views and beliefs about those treatments, and
trial participation happens in the absence of equipoise. Furthermore,
opting for surgical reconstruction does not necessarily provide patients
with satisfactory outcomes. This suggests that deﬁnition of successful
outcome may require an individualised approach, incorporating patients’
as well as surgeons’ views before treatment decisions are made.
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E.Y. Esina. Voronezh N.N. Burdenko State Medical Academy, Voronezh,
RUSSIAN FEDERATION
Purpose: Knee joints osteoarthritis (OA) is one of the most important
medical social problems. Therefore its study has become one of the
priority directions of the Bone and Joint Decade 2001–2010, Geneva
1999. The pathology of periarticular tissues worsens the course of knee
joints OA, but diagnostics and treatment in proper time improves the
quality of patients’ life. The purpose of the present work was to estimate
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the incidence of bursitis “pes anserinum” in patients with OA of knee
joints, its association with ﬂat-foot and the inﬂuence of complex treatment
with the use of insoles during disease’s course.
Methods: Patients consulted a rheumatologist on the occasion of wors-
ening the course of the disease. 52 patients with OA of knee joints
were examined. All patients were administered clinical and instrumental
examinations which included objective examination, full blood count,
urinalysis, blood serum creatinine, serum glutamic transaminase, serum
asparagines transaminase, the X-ray of knee joints, the ultrasonic exam-
ination of knee joints and periarticular tissues using the Sonoline G 50
device.
Results: The initial examination showed that most patients – 43 (82%)
had had a chronic recurrent course of the disease that had made them
take non-steroid anti-inﬂammatory medicines and use ointments. X-ray
stage I of the disease (Kellgren and Lawrence, 1957) was diagnosed in
10 (19%) patients, stage II and stage III – in 26 (50%) and 16 (31%)
patients respectively. Women (mean age 63) constituted 85% of the
whole patient’s group. The given proportion of women corresponded to
the epidemiological ﬁndings. On the average, all patients had a 6-year
history of the disease. Swelling of knee joints, tenderness along the
articular space and the periarticular area on the medial side were revealed
on palpation. The activity of the disease was evaluated by the patients
according to 100mm visual analogue scale (VAS). It was assessed by
the rheumatologist by the same scale. Pain at rest, pain during motion,
the quality of life were estimated by means of the questionnaire (HAG).
Bursitis “pes anserinum” was revealed in 22 (42%) patients, mainly with
stage II of knee joints’ OA and conﬁrmed by the ultrasonic examination of
the joints. Women’s mean age in this group was 66 years, all women were
overweighed. The diagnosis of combined (mainly longitudinal) stage I and
stage II ﬂat-foot in these patients was conﬁrmed by stereoplantopodog-
raphy and aroused their great interest invariably. When being asked the
patients said that they had experienced pain in their feet and tiredness of
their legs by the end of the day. The patients considered it to be natural
phenomenon which did not require any treatment. Complex non-medical
treatment included individual approach to every patient, wearing insoles
to correct ﬂat-foot, which enabled to improve the functional activity of
their knee joints, and was noted by the patients. Medical therapy was
identical for all patients and consisted of a non-steroid anti-inﬂammatory
medicine, intrajoint corticosteroids according to indications, periarticular
corticosteroids in the area of “pes anserinum”, physiotherapeutic treat-
ment (magnet therapy) and a symptomatic medicine of a slow action.
The received ﬁndings demonstrated a decrease of pain by 61mm (VAS)
and an improvement of the life quality by 4.7 points 10 days after the
treatment.
Conclusions: The correction of ﬂat-foot by means of knee joints’ OA
complex treatment enables to reduce the overload on the medial group of
femoral muscles and to stabilize the shin that abates the disease activity
and prolongs a stable course of the disease. The received ﬁndings have
revealed a low level of knowledge about ﬂat-foot as about a problem
which inﬂuences the normal functioning of feet and knee joints.
261 METABOLIC SYNDROME AND THE INCIDENCE OF
DEEP VEIN THROMBOSIS FOLLOWING TOTAL KNEE
ARTHROPLASTY
R. Gandhi. University of Toronto, Toronto, ON, CANADA
Purpose:We asked if patients with metabolic syndrome (MS) undergoing
total knee arthroplasty (TKA) have an increased risk for symptomatic
deep vein thrombosis (DVT).
Methods: We surveyed 1460 consecutive patients undergoing primary
TKA for relevant covariates. Metabolic syndrome was deﬁned as body
mass index above 30 kg/m2, diabetes, hypertension, and hypercholes-
terolemia.
Results: The overall incidence of symptomatic DVT was 4.4% (65/1460).
Patients with MS had an increased incidence of DVT as compared
to those without MS (15.5% vs 3.4%). Adjusted analysis showed that
MS increased the risk of symptomatic DVT by 4.2 (95% CI [1.5, 11.4],
p = 0.006) times compared to those without MS.
Conclusions: Protocols developed for prophylactic anti-coagulation
should give consideration to patients with metabolic syndrome.
262 18 MONTHS FOLLOWUP AFTER INTRA-ARTICULAR
ADMINISTRATION OF HYALUBRIX® IN 344 PATIENTS WITH
SYMPTOMATIC OSTEOARTHRITIS OF THE HIP
A. Migliore1, E. Bizzi1, U. Massafra1, A. Alimonti1, S. Martin Martin2,
S. Tormenta1. 1S. Pietro FBF Hospital, Rome, Italy, Rome, ITALY ,
2Regina Apostolorum Hospital, Albano Laziale, Rome, ITALY
Purpose: Investigation into the long term duration of beneﬁt after
ultrasound-guided intra-articular injection of Hyalubrix ® in patient with
hip OA.
Background: HYAP15 (Hyalubrix®) is a sterile, non pyrogenic, viscoelas-
tic solution manufactured with hyaluronic acid sodium salt for intra-
articular injection, obtained by bacterial fermentation from fraction of
high molecular weight (>1500 kDa) having Sodium hyaluronate 15mg/ml.
Hyalubrix® is marketed in Italy, Austria and Germany for the treatment of
degenerative or mechanical arthropathy and it is mainly used for the treat-
ment of the knee OA patients. A post marketing study on 1523 patients
affected by knee or hip OA supported the efﬁcacy and safety behaviour
of Hyalubrix® in pain reduction and functionality improvement. Literature
data regarding hip joint viscosupplementation are at now still limited to
small studies. We previously performed a comparative study for Hyalubrix
vs Carbocaine with a follow up of six months with good results in terms
of efﬁcacy and safety for Hyalubrix. Neverthless, at now there are no post
marketing cohort studies on hyalubrix in hip OA.
Methods: 344 adults, ambulatory patients suffering from hip OA grade 1
to 3 according to Kellgren and Lawrence were considered eligible for
the study. Patients were injected with two syringes (4ml) of Hyalubrix,
repeated every six month, and in some cases, if clinically requested, every
three months, under ultrasound guidance. A 3.5MHz convex transducer
was used with a sterilised biopsy guide attached. The hip joint was
scanned by means of an anterior parasagittal approach. The efﬁcacy
of the injection was assessed by using the Lequesne index and VAS pain
score at baseline and, then, every three months after the ﬁrst injection.
NSAIDs consumption was also evaluated during the month before the
injection and, then, every three months after ﬁrst the injection of Hylubrix
until to 18 months. Safety was assessed by recording any adverse event
during the follow up period.
Efﬁcacy of IA US-guided Hip injection of Hyalubrix® in OA affected
patients.
Table 1 Variations of the assessment criteria after repeated IA injections of Hyalubrix.
Baseline
(N=344)
3 months
(N=256)
6 months
(N=212)
9 months
(N=168)
12 months
(N=149)
15 months
(N=129)
18 months
(N=119)
OA pain VAS 5.8 4.3* 4.2* 4.1* 4.2* 4.1* 4.3*
NSAID
consumption
(Days/month)
6.7 4.4* 2.9* 3.2* 3.6* 3.8* 3.6*
Lequesne
index
7.5 5.6* 4.9* 5.0* 5.5* 5.6* 5.6*
*p< 0.01.
Results: 344 patients were treated, 166M and 177F. 32 had bilateral hip
OA. 8 patients left the study to undergo to hip replacement. 97 patients
are lost to follow up. No local or systemic adverse events were reported.
A statistically signiﬁcant reduction was observed at all time points versus
baseline for all assessment criteria, p< 0.01 (Tab. 1 and Fig. 1).
